These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7054283)

  • 1. Thioglycollate-elicited mouse peritoneal macrophages are less efficient than resident macrophages in antibody-dependent cell-mediated cytolysis.
    Shaw DR; Griffin FM
    J Immunol; 1982 Jan; 128(1):433-40. PubMed ID: 7054283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for Fc receptor-dependent cellular cytotoxicity and phagocytosis. Relationship to endogenous C1q availability.
    Leu RW; Zhou AQ; Rummage JA; Kennedy MJ; Shannon BJ
    J Immunol; 1989 Nov; 143(10):3250-7. PubMed ID: 2809201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced macrophage anti-microbial activity following dimethylnitrosamine exposure in vivo is related to augmented production of reactive oxygen metabolites.
    Edwards CK; Myers MJ; Kelley KW; Schook LB
    Immunopharmacol Immunotoxicol; 1991; 13(3):395-411. PubMed ID: 1940055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis.
    Leu RW; Zhou AQ; Kennedy MJ; Shannon BJ
    J Immunol; 1991 Feb; 146(4):1233-9. PubMed ID: 1991965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
    Rüegg SJ; Jungi TW
    Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of murine macrophage Fc receptor-dependent phagocytosis and antibody-dependent cellular cytotoxicity during in vitro culture with interferons-gamma, alpha/beta and/or fetal bovine serum.
    Leu RW; Rummage JA; Horn MJ
    Immunobiology; 1989 Feb; 178(4-5):340-50. PubMed ID: 2469639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity.
    Roubin R; Dulioust A; Haye-Legrand I; Ninio E; Benveniste J
    J Immunol; 1986 Mar; 136(5):1796-802. PubMed ID: 3950403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.
    Boraschi D; Niederhuber JE
    J Immunol; 1982 Nov; 129(5):1854-8. PubMed ID: 6956630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F4/80, a monoclonal antibody directed specifically against the mouse macrophage.
    Austyn JM; Gordon S
    Eur J Immunol; 1981 Oct; 11(10):805-15. PubMed ID: 7308288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between membrane potential changes and superoxide-releasing capacity in resident and activated mouse peritoneal macrophages.
    Kitagawa S; Johnston RB
    J Immunol; 1985 Nov; 135(5):3417-23. PubMed ID: 2995493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc receptors for IgE on mouse macrophages and macrophage-like cell lines.
    Boltz-Nitulescu G; Plummer JM; Spiegelberg HL
    J Immunol; 1982 May; 128(5):2265-8. PubMed ID: 7061861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S; Lint TF
    J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.
    Matthews TJ; Weinhold KJ; Langlois AJ; Bolognesi DP
    J Natl Cancer Inst; 1985 Oct; 75(4):703-8. PubMed ID: 3862902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role for macrophages: the ability of macrophages to tolerize B cells.
    Phipps RP; Scott DW
    J Immunol; 1983 Nov; 131(5):2122-7. PubMed ID: 6195250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-beta-induced reduction of superoxide anion generation by macrophages.
    Boraschi D; Ghezzi P; Salmona M; Tagliabue A
    Immunology; 1982 Apr; 45(4):621-8. PubMed ID: 6175565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of macrophage immune and nonimmune receptor-mediated phagocytosis by a low molecular weight soluble factor from resident thymocytes.
    Coleman DL; Culver KE; Ryan JL
    J Immunol; 1984 Dec; 133(6):3121-7. PubMed ID: 6386982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
    Akiyama Y; Yamasaki T; Fukuda M; Moritake K
    No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.
    Boraschi D; Ghezzi P; Pasqualetto E; Salmona M; Nencioni L; Soldateschi D; Villa L; Tagliabue A
    Immunology; 1983 Nov; 50(3):359-68. PubMed ID: 6354920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages.
    Rothlein R; Springer TA
    J Immunol; 1985 Oct; 135(4):2668-72. PubMed ID: 3897377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.